|
|
Article: FDA issues draft guidelines on drug-eluting stents.(Medical Devices)
- Article from:
- Adverse Event Reporting News
- Article date:
- April 8, 2008
|
Copyright informationCOPYRIGHT 2008 Washington Information Source, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
FDA Commissioner Andrew von Eschenbach announced March 31 that the agency has issued draft guidelines to aid the development, testing and manufacture of coronary drug-eluting stents, devices used to treat blocked heart arteries.
Over the past few years, FDA and the clinical community have been closely monitoring these devices, including concerns over clot formation in some patients several years after implantation, the agency announced. The draft guidelines issued outline FDA's recommendations for pre-market clinical evaluation and post-market studies, "which may provide data to better address this and other potential safety concerns."
In its most rigorous ...
Related newspaper, magazine, and journal articles:
|
|
Article: FDA Told to Make Changes in Biotech Foods Review Process.(Brief Article)
Food & Drink Weekly;
December 6, 1999 ;
539 words
...FDA's second installment of its cross-country public listening...corncob that read Safety First. Joseph Levitt, director of FDA's Center for Food Safety and Applied Nutrition, said since...tools of biotechnology. Levitt said in the past five years, FDA has had over 40 consultations with companies concerning ...
|
|